Ganglionic Stimulants

DBCAT000446Pharmacologic class

Agents that mimic neural transmission by stimulation of the nicotinic receptors on postganglionic autonomic neurons. Drugs that indirectly augment ganglionic transmission by increasing the release or slowing the breakdown of acetylcholine or by non-nicotinic effects... A DrugBank category of 3 drugs. 1 of them is approved.

Also known as: Stimulants, Ganglionic
Drugs: Lobeline
Nicotine
Tetramethylammonium

What you can answer from here — as of August 24, 2016

3DrugsEach linked to its full drug card

Listed above

15Drug targetsEvery drug–target pair in the class, with bond type

1,846Marketed productsAcross the regions we cover, with dosage forms and routes

10Routes of administrationHow the drugs in this class are given

Which targets do Ganglionic Stimulants share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account